Astronaut Andy Thomas opens UNSW's new Australian Centre for Astrobiology and gives education funding a serve.

US venture capitalist Osagie Imasogie told AusBiotech 2005 that biotech companies need to get aggressive when it comes to finding opportunities.

After a year scouting for its first deal, private Brisbane biotech Implicit Biosciences is hoping to raise a phoenix from the ashes of a dead US company, Cytran, which went bankrupt in 2002 after the Phase III failure of its lead candidate IM862.

Early Australian settlers evocatively dubbed fire 'the red steer' -- the untamed beast that rampaged through the bush, grazing it back to bare earth. 'Red prince' might have been more appropriate, because the smoke from bushfires delivers a potent chemical kiss that rouses the sleeping seeds of many native plants -- including many of Australia's most beauteous species -- to vibrant life.

Phosphagenics (ASX:POH) -– formerly Vital Capital -– has announced the successful completion of animal studies for its transdermal delivery system for morphine.

The list of the world's top 500 supercomputers, presented at last week's SC2003 Igniting Innovation conference in Phoenix, contains several notable new life science entries.